Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05513703
Title A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AbbVie
Indications

lung non-squamous non-small cell carcinoma

Therapies

Telisotuzumab vedotin

Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | DEU

Additional content available in CKB BOOST